Altogether, these observations are summarized in Fig. 5D: in cancer context, onco-suppressors are repressed while oncogenes are hyper-activated due to the aberrant functions of EZH2, MYC and YAP/TAZ. This evidence concerns the gene EZH2 and cancer.